Active Ingredient: Adalimumab; Atc Code: L04Ab04; Dosage Tender

• Country: Germany
• Summary: Active Ingredient: Adalimumab; Atc Code: L04Ab04; Dosage Form: All; Potency: All; Pack Size: all (Excluding Clinical Packs)
• DET Ref No: 139938652
• Deadline: 05 May 2026
• Financier: Self Financed
• Purchaser Ownership: Government
• Tender Value: Refer Document
• Notice Type: Tender
• Document Ref. No.: 0000/0016
• Purchaser's Detail:
  Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.

  Login to see details
• Description:
• This announcement serves to conclude drug discount contracts in accordance with Section 130a Paragraph 8 or 130c Paragraph 1 SGB V for the active ingredient(s) mentioned under the title. This does not involve the award of public contracts within the meaning of the directive 2014/24/EU or Sections 97 ff GWB. Any pharmaceutical company can become a contractual partner in accordance with Section 4 Paragraph 18 AMG. According to the case law of the European Court of Justice, such approval procedures are not necessarily subject to public procurement law, as due to the lack of selection decision no competition takes place. The announcement serves as an invitation to conclude discount agreements with conditions that apply equally to all contractual partners and are not subject to discretion, including the determination of the discount. The The contract is concluded by signing the contract documents and submitting the required declarations, which can be requested from the designated contact point. Pharmaceutical products (CPV code: 33600000)
• Documents:

 Tender Notice